Economic Information Daily News Agency reported on the 30th that Jinxi Reproductive (01951) is currently up 3.1%, trading at HK$2.17. Based on the current price, the stock has risen for two consecutive days, with a cumulative increase of 3.3%. The stock's trading volume is approximately 10.03 million shares, involving a turnover of HK$21.57 million.
Jinxi Reproductive announced that it proposes to issue asset-backed securities (REITs), with the expected total fundraising amount of approximately RMB 1.93 billion.
The group stated that about 80% of the asset-backed securities are expected to be issued to professional institutional investors, while the group itself expects to subscribe for approximately 20% of the asset-backed securities. The consideration for the asset-backed special purpose vehicle manager to acquire assets from the group is expected not to exceed the proposed fundraising amount. The underlying assets to be sold into the asset-backed special purpose plan are Hengyu, which holds the Shenzhen property. The property is primarily used by Shenzhen Zhongshan Hospital to provide medical services, with a total floor area of 78,000 square meters. Hengyu recorded a loss of RMB 2.65 million in the first half of this year.
The group expects to receive net proceeds of approximately RMB 1.2 billion, which will be used to repay debt and for general working capital purposes. Based on the financial position as of June 30 this year, the proposed issuance is expected to reduce the net debt to EBITDA ratio from approximately 2.8 times to approximately 0.9 times. (am)
Jinxi Reproductive announced that it proposes to issue asset-backed securities (REITs), with the expected total fundraising amount of approximately RMB 1.93 billion.
The group stated that about 80% of the asset-backed securities are expected to be issued to professional institutional investors, while the group itself expects to subscribe for approximately 20% of the asset-backed securities. The consideration for the asset-backed special purpose vehicle manager to acquire assets from the group is expected not to exceed the proposed fundraising amount. The underlying assets to be sold into the asset-backed special purpose plan are Hengyu, which holds the Shenzhen property. The property is primarily used by Shenzhen Zhongshan Hospital to provide medical services, with a total floor area of 78,000 square meters. Hengyu recorded a loss of RMB 2.65 million in the first half of this year.
The group expects to receive net proceeds of approximately RMB 1.2 billion, which will be used to repay debt and for general working capital purposes. Based on the financial position as of June 30 this year, the proposed issuance is expected to reduce the net debt to EBITDA ratio from approximately 2.8 times to approximately 0.9 times. (am)
